nanowattdesign.com
Board of Directors
http://www.nanowattdesign.com/index.php/about/board-of-directors
Ronald Foster, Cofounder, Chairman. Omid Moghadam, Director. Dr Calvin Goforth, Director. Richard L. Bond, Director. NanoWatt Design, Inc. 700 W. Research Center Blvd. Suite 1620, M/S 2500 Fayetteville, AR 72701 tel 479.527.6510 • fax 479.571.8814. NanoWatt Design is a VIC.
nanowattdesign.com
About
http://www.nanowattdesign.com/index.php/about
NanoWatt works with both standard cell and custom libraries. SCL optionally makes use of a custom library, and promises 3 - 8x reduction in standby leakage power. The company is currently focused on bringing to market a Sensor Hub solution operating in the range of 0.3 – 0.6 volts. The Sensor Hub is functionally similar to a microcontroller (MCU). nanoWatt is currently applying multiple patent-pending approaches to optimize a Sensor Hub design for lowest overall energy consumption. Multi-core operation o...
nanowattdesign.com
Executives
http://www.nanowattdesign.com/index.php/about/executives
J Scott Gardner, Chief Executive Officer. Ronald Foster, Cofounder, Chairman, and Chief Operating Officer. Parviz Palangpour, Ph.D., Chief Technology Officer. NanoWatt Design, Inc. 700 W. Research Center Blvd. Suite 1620, M/S 2500 Fayetteville, AR 72701 tel 479.527.6510 • fax 479.571.8814. NanoWatt Design is a VIC.
sevonutraceuticals.com
News | Sevo Nutraceuticals, Inc.
http://www.sevonutraceuticals.com/news16_ClinStud_AlzAssn.html
Sevo Nutraceuticals Announces Publication of. Clinical Studies Funded by Alzheimer’s Association. WALTHAM, MA January 15, 2015 Sevo Nutraceuticals, Inc. announced today that. Phase II clinical trial results were published this month in the online version of the. Journal of Alzheimer’s Disease. Is its clinically proven, cognitive health supplement available to the public without a prescription. Values above represent the % improvement for individuals receiving the PERCEPTIV formulation for nine months.
sevonutraceuticals.com
Leadership | Sevo Nutraceuticals, Inc.
http://www.sevonutraceuticals.com/aboutb.html
In addition to Bernie Prusaczyk, the Sevo Nutraceuticals Board comprises:. Dr Calvin Goforth, Chairman,. Robert C. Gore. Sevo Nutraceuticals, Inc. 800 Main Street Holden, MA 01520-1838 508.829.8046. Sevo Nutraceuticals is a VIC.
sevonutraceuticals.com
News & Events | Sevo Nutraceuticals, Inc.
http://www.sevonutraceuticals.com/newsandevents.html
Shows Significant Improvement in Cases of Mild Cognitive Impairment. Article from NutraIngredients-USA by Hank Schultz:. A multi-ingredient formula (. Previously studied for cognitive effects has additional evidence to bolster its efficacy in cases of mild cognitive impairment with the results of a recent study. Participants in a long-term trial showed significant improvements in memory performance and cognitive scores. Sevo Nutraceuticals Announces Publication of. Sevo Nutraceuticals Continues to Grow.
sevonutraceuticals.com
Sevo Nutraceuticals, Inc.
http://www.sevonutraceuticals.com/index.html
Our vision is to become a market leader in highly efficacious,. Science-backed nutraceuticals that improve people's. Our first product, is a clinically proven nutraceutical that improves mental clarity, memory recall, focus and concentration. Shows Significant Improvement in Mild Cognitive Impairment. Publication of Clinical Studies of. Funded by Alzheimer’s Association Announced. Sevo Nutraceuticals, Inc. 800 Main Street Holden, MA 01520-1838 508.829.8046. Sevo Nutraceuticals is a VIC.
akesobiomedical.com
Akeso Biomedical Home
http://www.akesobiomedical.com/index.html
Akeso Biomedical is developing a new generation of compounds,. Known as Fe3C, with broad-spectrum activity to fight bacterial infections,. And prevent foodborne illnesses. The company’s proprietary technology is being used initially to develop a feed additive designed to prevent food poisoning by Campylobacter, a bacteria that causes more cases of foodborne illness in the EU than Salmonella, E. coli, and Listeria combined. Akeso Biomedical is a VIC.